Intracranial Hypertension Clinical Trial
Official title:
Sodium-Lactate Versus Mannitol in the Treatment of Intracranial Hypertensive Episodes in Severe Traumatic Brain Injured Patients
The purpose of this study is to compare the effect of bolus of either sodium-lactate or mannitol on the evolution of intracranial pressure (ICP) during intracranial hypertensive episodes (IHE)
Osmotherapy with mannitol remains the first treatment currently recommended to treat
intracranial hypertension in severe head injury.However, this treatment in not always
efficient and is associated with side-effects and a transitory action. Hypertonic
sodium-lactate, by its osmotic and energetic properties could be superior to mannitol to
decrease ICP. Study objectives : to compare the effect of mannitol and sodium-lactate on ICP
at the fourth hour after the start of infusion during IHE in severe traumatic brain injury
(TBI) (main endpoint) ; to compare the percentage of successfully treated episodes between
both treatments and to compare the neurological status after one year of evolution (glasgow
outcome score)(secondary endpoints)
Patients inclusion : adult severe TBI (glasgow coma score < 9) < 66 yrs Exclusion criteria :
polytrauma, bilateral fixed dilated pupils, motor score < 4, neurosurgery, prolonged episode
of hypoxia or arterial hypotension, 34 patients included from november 2003 to november 2004
and randomized into two groups : MAN group receiving mannitol 20% 100 ml in 15 min (17
patients, 36 episodes of IHE treated) and LAC group receiving semimolar sodium-lactate 100
ml in 15 min (17 patients, 37 episodes of IHE treated). For ethical reasons a rescue
treatment in a crossover fashion was performed for each episode of IHE when the randomized
treatment failed.
Follow-up : one year after the TBI. Study end : november 30, 2005
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06367868 -
Optic Nerve Sheath Diameter: A Non-Invasive Indicator of Intracranial Pressure in the Intensive Care Unit Monitoring
|
N/A | |
Completed |
NCT04488874 -
Sodium Lactate and Brain Relaxation (LSD)
|
Phase 3 | |
Not yet recruiting |
NCT04211064 -
Comparison of the Effects of Deep and Moderate Neuromuscular Blockade on Optic Nerve Sheath Diameter
|
N/A | |
Completed |
NCT00571623 -
Automated Chest Physiotherapy to Improve Outcomes in Neuro
|
N/A | |
Recruiting |
NCT00437814 -
Effect of Ketamine (Ketalar) on Intracranial Pressure
|
N/A | |
Recruiting |
NCT03212976 -
Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure
|
N/A | |
Withdrawn |
NCT02558309 -
Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure
|
N/A | |
Terminated |
NCT00795587 -
Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring
|
Phase 4 | |
Completed |
NCT00447018 -
Mannitol Versus Hypertonic Saline Solution in the Treatment of Elevated Intracranial Pressure
|
Phase 4 | |
Not yet recruiting |
NCT05593380 -
The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH
|
N/A | |
Completed |
NCT03364634 -
Intracranial Pressure After Decompressive Craniectomy
|
N/A | |
Unknown status |
NCT02773901 -
Comparison of the Non-invasive ICP HeadSense Monitor vs Lumbar CSF Pressure Measurement
|
N/A | |
Terminated |
NCT01973764 -
Intraventricular Drain Insertion: Comparison of Ultrasound-guided and Landmark-based Puncture of the Ventricular System
|
N/A | |
Recruiting |
NCT04459806 -
Intracranial PrEssure Time dOse (ImPETO)
|
||
Completed |
NCT00239525 -
3-D Transcranial Ultrasound Analysis Study
|
N/A | |
Completed |
NCT05946200 -
Optic Nerve Sheath Diameter in Low-flow and Normal-flow Rate Anesthesia
|
N/A | |
Completed |
NCT03957837 -
Optical Nerve Sheath Changes During Head Down Laparoscopy
|
||
Not yet recruiting |
NCT05818371 -
Non-invasive ONSD-based Neuromonitoring in a Neurointensive Care Setting
|
N/A | |
Completed |
NCT04429477 -
Cerebral Compliance Impairment in COVID-19
|
||
Recruiting |
NCT03144219 -
A Novel Non-invasive Technique of Cerebral Compliance and Auto-regulation Assessment
|